October 12, 2020
Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.
October 1, 2020
Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.
June 4, 2020
November 14, 2019
Designing a clinical trial database is a balancing act. Any clinical program has multiple stakeholders who have both short-term and long-term goals to achieve. A good database designer must understand the needs and goals of the sponsor and its various functional project team members. The designer must consider the ease of use for the clinical trial sites who will be entering the trial data, with the needs of the downstream stakeholders in biostatistics, programming, and medical writing. Additionally, we not only need to consider today’s priorities, we also must understand the overall strategy of the clinical program, especially as it moves forward past the current stage.
October 24, 2019
Veristat will be attending Clinical Trials Europe 2019, the conference formerly known as the Partnerships in Clinical Trial Europe conference, for the first time this year.
October 8, 2019
Join Veristat at AMWA 2019 Medical Writing & Communication Conference to learn about the trends and opportunities in the field of medical writing and medical communications.
August 29, 2019
Veristat is excited to be heading to the Evolution Summit Fall 2019 taking place on Sept 11-13, 2019 in San Diego, CA. We will be co-hosting a Master Class session on Successful Sponsor/CRO Partnerships.